Resveratrol Could Suppress Pathogen that Causes Inflammation

636125556337570698^A49F39700069E1FC93AF81B064B13A4296651593A7481E89AF^pimgpsh_fullsize_distr.jpg

20 Oct 2016 --- Resveratrol, a component of red wine and grapes, may help control inflammation induced by a bacterial pathogen that is linked to upper respiratory tract inflammatory diseases, according to a new study published in Scientific Reports.

“It has been shown that resveratrol can suppress inflammation, but how it regulates inflammation still remains largely unknown,” said Jian-Dong Li, a senior author of the study, director of the Institute for Biomedical Sciences at Georgia State, and a Georgia Research Alliance Eminent Scholar.

“We found that resveratrol suppresses a major bacterial pathogen causing otitis media and chronic obstructive pulmonary diseases (COPD) by up-regulating or increasing the production of a negative regulator called MyD88 short.”

Resveratrol belongs to a group of compounds called polyphenols that are thought to act like antioxidants and protect the body against damage. It has long been considered a therapeutic agent for various diseases, including inflammatory diseases.

In the study, resveratrol was effective against inflammation caused by nontypeable Haemophilus influenzae (NTHi), a major respiratory pathogen.

This study found for the first time that resveratrol decreases NTHi-induced expression of pro-inflammatory mediators in airway epithelial cells and in the lungs of mice by enhancing MyD88 short, a negative regulator of inflammatory signaling pathways.

MyD88 short is considered a “brake pedal protein” because it can tightly control inflammation induced by this respiratory pathogen. It could be a critical target with significant therapeutic potential for suppressing inflammation associated with chronic airway disease.

The researchers also found that resveratrol has anti-inflammatory effects after NTHi infection, which demonstrates its therapeutic potential.

RELATED ARTICLES
Homepicture

Seventure Partners’ microbiome portfolio nears critical milestones 

18 Dec 2017 Seventure Partners, one of Europe’s ...

Homepicture

Soylent returns to Silicon Valley roots with retail expansion

15 Dec 2017 Rosa Foods, the makers of Soylent, has announced ...

Homepicture

Nutrition 21 launches US media campaign to support Velositol ingredient

11 Dec 2017 Nutrition 21, LLC has partnered with NYC-based ...

Homepicture

Pea stars for Roquette amid alternative protein boom

11 Dec 2017 Roquette’s range of pea proteins took a ...

Homepicture

Inflammatory bowel disease rates on the rise outside West, says new study

08 Dec 2017 Countries in Africa, Asia, the Middle East and ...